Results 31 to 40 of about 11,751,314 (295)

Withholding or withdrawing life-sustaining treatment in extremely low gestational age neonates

Archives of Disease in Childhood, 2020
Objective To identify sociodemographic and clinical factors associated with withholding or withdrawing life-sustaining treatment (WWLST) for extremely low gestational age neonates.
April R. Dworetz, G. Natarajan, John C. Langer, K. Kinlaw, Jennifer James, M. Bidegain, A. Das, B. Poindexter, Edward F Bell, C. Cotten, H. Kirpalani, S. Shankaran, Barbara J. Stoll   +12 more
semanticscholar   +1 more source

Why do we Discontinue Biologic Agents? A Retrospective Study of 11 Years

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2020
Introduction: Biologic agents acquired a growing relevance in dermatology, however, adverse events (AE) and reasons to discontinue therapy are not completely known.
Francisco Gil, Margarida Rato, Ana Monteiro, Joana Parente, César Martins, João Aranha, Maria João Silva   +6 more
doaj   +1 more source

Physicians’ attitudes and experiences about withholding/withdrawing life-sustaining treatments in pediatrics: a systematic review of quantitative evidence

BMC Palliative Care, 2023
Background One of the most important and ethically challenging decisions made for children with life-limiting conditions is withholding/withdrawing life-sustaining treatments (LST).
Yajing Zhong, Alice Cavolo, Veerle Labarque, Chris Gastmans   +3 more
doaj   +1 more source

Are medical ethicists out of touch? Practitioner attitudes in the US and UK towards decisions at the end of life [PDF]

, 2000
To assess whether UK and US health care professionals share the views of medical ethicists about medical futility, withdrawing/withholding treatment, ordinary/extraordinary interventions, and the doctrine of double effect.
Dickenson, Donna
core   +3 more sources

The Ethics of Placebo-controlled Trials: Methodological Justifications [PDF]

, 2013
The use of placebo controls in clinical trials remains controversial. Ethical analysis and international ethical guidance permit the use of placebo controls in randomized trials when scientifically indicated in four cases: (1) when there is no proven ...
Grady, Christine, Millum, Joseph
core   +1 more source

Withdrawal from long-term hemodialysis in patients with end-stage renal disease in Taiwan

Journal of the Formosan Medical Association, 2013
Withdrawal from dialysis is ethically appropriate for some patients with multiple comorbidities and a shortened life expectancy. Taiwan has the highest prevalence of dialysis patients in the world, and the National Health Insurance (NHI) program offers ...
Chun-Fu Lai, Hung-Bin Tsai, Su-Hsuan Hsu, Chih-Kang Chiang, Jenq-Wen Huang, Sheng-Jean Huang   +5 more
doaj   +1 more source

End of life in the critically ill patient: evaluation of experience of end of life by caregivers (EOLE study)

Annals of Intensive Care, 2021
Background The death rate in intensive care units (ICUs) can reach 20%. More than half occurs after a decision of care withholding/withdrawal. We aimed at describing and evaluating the experience of ICU physicians and nurses involved in the end-of-life ...
The SRLF Trial Group
doaj   +1 more source

Reasons withholding intravenous thrombolysis for acute ischemic stroke in an Indonesian Tertiary Center

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2023
Background Intravenous thrombolysis is the current therapy of choice in patients with acute ischemic stroke (AIS). While highly effective, the rate at which the procedure is employed is low.
Rocksy Fransisca V. Situmeang, Aristo Pangestu, Reza Stevano, Yesenia Tannu, Jessica Herlambang, Cynthia Putri   +5 more
doaj   +1 more source

The Brazilian policy of withholding treatment for ADHD is probably increasing health and social costs.

Revista Brasileira de Psiquiatria, 2015
OBJECTIVE To estimate the economic consequences of the current Brazilian government policy for attention-deficit/hyperactivity disorder (ADHD) treatment and how much the country would save if treatment with immediate-release methylphenidate (MPH-IR), as ...
C. R. Maia, S. F. Stella, P. Mattos, G. Polanczyk, C. Polanczyk, L. Rohde   +5 more
semanticscholar   +1 more source

Perfil das condutas médicas que antecedem ao óbito de crianças em um hospital terciário A profile of the medical conduct preceding child death at a tertiary hospital

Jornal de Pediatria, 2005
OBJETIVO: estudar o perfil de assistência aos pacientes pediátricos que evoluem para o óbito em um hospital universitário, incluindo descrição dos modelos, comparações entre setores, associações de fatores, participações envolvidas e registro das ...
Henrique A.F. Tonelli, Joaquim A.C. Mota, José S. Oliveira   +2 more
doaj   +1 more source